<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04726943</url>
  </required_header>
  <id_info>
    <org_study_id>TCAI_RFLK01</org_study_id>
    <nct_id>NCT04726943</nct_id>
  </id_info>
  <brief_title>RF Applications for Residual LAA Leaks</brief_title>
  <acronym>REACT</acronym>
  <official_title>Radiofrequency Energy Applications Targeting Significant Residual Leaks After Left Atrial Appendage Occlusion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Texas Cardiac Arrhythmia Research Foundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Texas Cardiac Arrhythmia Research Foundation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Although the clinical impact of residual left atrial appendage (LAA) leaks still requires&#xD;
      confirmation, its patency resulting from incomplete LAA closure may promote blood stagnation&#xD;
      and thrombus formation, and increase the risk of thromboembolic events. The main purpose of&#xD;
      this trial is to evaluate the safety and efficacy of percutaneous leak closure with&#xD;
      radiofrequency energy applications.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Therapies locally targeting the LAA via occlusion, exclusion, or excision have emerged as an&#xD;
      alternative and effective approach for stroke prophylaxis in AF patients, especially those&#xD;
      with OAC contra-indications. Despite mounting evidence of their safety and efficacy in&#xD;
      comparison with standard oral therapy, device-related thrombus and incomplete LAA closure&#xD;
      resulting in residual, significant leak may occur, potentially hindering an effective stroke&#xD;
      prevention. Radiofrequency energy has been adopted in several settings (e.g., vascular,&#xD;
      orthopedic, aesthetic surgery) to achieve thermal-induced tissue retraction.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Procedural Success</measure>
    <time_frame>1-3 months</time_frame>
    <description>Complete LAA occlusion or presence of a mild/minimal peri-device leak on FU TEE</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Peri-Procedural Success</measure>
    <time_frame>Peri-Procedural</time_frame>
    <description>Complete LAA occlusion or presence of mild/minimal (1-2 mm) residual leak assessed via multiplane color Doppler imaging on TEE/ICE at the end of the procedure</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Left Atrial Appendage Thrombosis</condition>
  <condition>Stroke, Ischemic</condition>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>RF Energy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>RF delivery targeting the atrial side of a significant residual leak in patients with acute and chronic evidence of incomplete percutaneous LAA occlusion</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Radiofrequency Energy Applications</intervention_name>
    <description>RF energy applications to the atrial edge of a leak resulting from incomplete LAA occlusion</description>
    <arm_group_label>RF Energy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age&gt; 18 years.&#xD;
&#xD;
          2. Presence of a significant LAA leak acutely or at follow-up.&#xD;
&#xD;
          3. Written informed consent obtained from subject or subject's legal representative and&#xD;
             ability for subject to comply with the requirements of the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Life expectancy &lt; 2 years.&#xD;
&#xD;
          2. pregnant, breastfeeding, or unwilling to practice birth control during participation&#xD;
             in the study&#xD;
&#xD;
          3. presence of a condition or abnormality that in the opinion of the Investigator would&#xD;
             compromise the safety of the patient or the quality of the data&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Andrea Natale, MD</last_name>
    <phone>512 544 8186</phone>
    <email>dr.natale@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Domenico G Della Rocca, MD</last_name>
    <phone>512 544 8186</phone>
    <email>domenicodellarocca@hotmail.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kansas City Heart Rhythm Institute</name>
      <address>
        <city>Overland Park</city>
        <state>Kansas</state>
        <zip>66615</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Dhanunjaya Lakkireddy, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. David's Medical Center</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78723</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Domenico G Della Rocca, MD</last_name>
      <phone>512-544-8186</phone>
      <email>domenicodellarocca@hotmail.it</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>January 19, 2021</study_first_submitted>
  <study_first_submitted_qc>January 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 27, 2021</study_first_posted>
  <last_update_submitted>February 8, 2021</last_update_submitted>
  <last_update_submitted_qc>February 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Texas Cardiac Arrhythmia Research Foundation</investigator_affiliation>
    <investigator_full_name>Andrea Natale</investigator_full_name>
    <investigator_title>Executive Medical Director</investigator_title>
  </responsible_party>
  <keyword>stroke</keyword>
  <keyword>atrial fibrillation</keyword>
  <keyword>left atrial appendage</keyword>
  <keyword>prevention</keyword>
  <keyword>leak</keyword>
  <keyword>radiofrequency</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemic Stroke</mesh_term>
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Thrombosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

